UM Cure 2020 is a new European Consortium to foster research on metastatic uveal melanoma and identify new treatments for this serious disease. Under the coordination of Institut Curie in Paris, PEP-Therapy and 11 other partners have received 6 million euros of funding from the European Union’s Horizon 2020 research and innovation programme to identify new therapeutic approaches to treat metastatic uveal melanoma in a 5-year project.